Claudio Albrecht is set to become the new CEO of Actavis Group. Release
Phytopharm has appointed Tim Sharpington as CEO and board director. Release
Jennerex has announced the appointment of Gregory Schafer as senior VP and CFO. Release
Farouk Dakhil has been named Xytos' new chief scientific officer and the head of its scientific advisory board. Release
BrainStorm Cell Therapeutics has named Liat Sossover as its CFO. Release
Spectrum Pharmaceuticals has appointed James Shields to the position of senior VP and chief commercial officer. Release
Jessica Mann will resign as chief medical officer of Evolva and join Roche as head of translational medicine. Release
Spencer Pharmaceutical has announced that Max Arella will be president and chairman of the company. Release
Bausch + Lomb has appointed Rodney Unsworth as president, Asia-Pacific, effective July 1. Release
Ariad Pharmaceuticals has tapped Timothy Clackson as its first president of R&D. Release
NexMed has appointed Deirdre Gillespie, president and CEO of La Jolla Pharmaceutical Company, to its board. Release
International Stem Cell Corporation has announced that Charles Casamento has been elected to the board of directors. Release
Jack Wyszomierski has been elected to Athersys' board of directors. Jordan Davis and William Mulligan did not stand for re-election. Release
ZymoGenetics has announced that Novo Nordisk's Lars Fruergaard Jørgensen was elected to the company's board of directors. He replaces Lars Rebien Sørensen, a previous Novo Nordisk representative, who resigned from the board in March. Release
Idera Pharmaceuticals has elected Eve Slater to its board. Release